Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2017136303) TRANSDERMAL DRUG DELIVERY SYSTEMS WITH FLUOROSILICONE RELEASE LINERS
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2017/136303 International Application No.: PCT/US2017/015724
Publication Date: 10.08.2017 International Filing Date: 31.01.2017
IPC:
A61K 9/70 (2006.01) ,A61K 31/167 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
70
Web, sheet or filament bases
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
16
Amides, e.g. hydroxamic acids
165
having aromatic rings, e.g. colchicine, atenolol, progabide
167
having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
Applicants:
3M INNOVATIVE PROPERTIES COMPANY [US/US]; 3M Center Post Office Box 33427 Saint Paul, Minnesota 55133-3427, US
Inventors:
CARVAJAL, Daniel; US
LARSON, Ricky L.; US
MCNAMARA, Gene P.; US
KLUGE, Bruce D.; US
BOARDMAN, Larry D.; US
Agent:
SILVERMAN, Eric E.; US
RHODES, Kevin H.,; US
BLANK, Colene H.,; US
FLORCZAK, Yen Tong,; US
HARTS, Dean M. ,; US
LEVINSON, Eric D.,; US
MAKI, Eloise J.,; US
NOWAK, Sandra K.,; US
OLSON, Peter L.,; US
RINGSRED, Ted K.,; US
Priority Data:
62/291,78205.02.2016US
Title (EN) TRANSDERMAL DRUG DELIVERY SYSTEMS WITH FLUOROSILICONE RELEASE LINERS
(FR) SYSTÈMES D'ADMINISTRATION TRANSDERMIQUE DE MÉDICAMENT COMPRENANT DES REVÊTEMENTS ANTIADHÉSIFS EN FLUOROSILICONE
Abstract:
(EN) Fluorosilicone containing release liners for transdermal drug delivery systems, such as transdermal patches, transdermal drug delivery systems containing such release liners, and methods of delivering active pharmaceutical ingredients using the same.
(FR) L’invention concerne des revêtements de libération de substances, contenant du fluorosilicone, destinés à des systèmes d'administration transdermique de médicament tels que des patchs transdermiques, des systèmes d'administration transdermique de médicament comprenant de tels revêtements de libération de substances, et des méthodes pour administrer des principes actifs pharmaceutiques au moyen de ces systèmes.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
CN108601749EP3411023